Alpa Laboratories Balance Sheet Annual

Trade

BSE: 532878 | NSE: ALPA | ISIN: INE385I01010 | Sector: Biotechnology & Drugs

110.75 -2.55 (-2.25%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	1.65	8.81	1.58	10.51
Cash Equivalents	0.06	-	-	-
Short Term Investments	92.97	75.62	74.94	47.28
Cashand Short Term Investments	94.68	84.43	76.52	57.79
Accounts Receivable- Trade Net	41.40	46.73	38.04	35.43
Total Receivables Net	43.91	47.45	38.76	35.97
Total Inventory	13.67	13.71	15.46	16.56
Other Current Assets Total	8.97	3.29	8.20	10.77
Total Current Assets	161.23	149.13	138.94	121.09
Property/ Plant/ Equipment Total- Net	11.41	6.96	9.22	8.73
Intangibles Net	0.06	0.08	-	-
Long Term Investments	9.92	11.10	6.98	10.49
Other Long Term Assets Total	0.00	0.00	0.00	0.00
Total Assets	182.62	167.27	155.24	140.37
Accounts Payable	11.78	15.06	14.92	24.73
Current Portof LT Debt/ Capital Leases	5.25	1.53	1.38	0.18
Other Currentliabilities Total	11.29	15.33	12.74	7.59
Total Current Liabilities	28.32	31.92	31.38	32.50
Long Term Debt	0.00	0.78	2.12	0.01
Total Long Term Debt	0.00	0.78	2.12	0.01
Total Debt	5.25	2.30	5.85	0.19
Deferred Income Tax	2.40	-	-	0.22
Other Liabilities Total	0.00	0.00	0.00	-
Total Liabilities	30.71	32.69	33.51	32.73
Common Stock Total	21.04	21.04	21.04	21.04
Retained Earnings( Accumulated Deficit)	130.87	58.58	100.69	86.60
Total Equity	151.91	134.58	121.73	107.64
Total Liabilities Shareholders' Equity	182.62	167.27	155.24	140.37
Total Common Shares Outstanding	2.10	2.10	2.10	2.10
Tangible Book Valueper Share Common Eq	72.17	63.92	57.81	51.13
Prepaid Expenses	-	0.25	-	-
Property/ Plant/ Equipment Total- Gross	-	33.33	-	-
Accumulated Depreciation Total	-	-26.38	-	-
Accrued Expenses	-	0.00	-	-
Notes Payable/ Short Term Debt	-	0.00	2.34	0.00
Additional Paid- In Capital	-	54.96	-	-
Goodwill Net	-	-	0.10	0.06